Realcan Pharmaceutical Group Co., Ltd. (002589.SZ)

Home
002589.SZ
Financials

3.35 (CNY) • At close October 26, 2023

Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Revenue Numbers are in millions	8,034.368	12,311.278	21,059.719	27,203.884	35,258.509	33,918.534	23,293.62	15,618.666	9,749.958	7,785.907	5,925.842	4,622.238	3,195.448	2,213.383	1,601.731	1,147.11
Cost of Revenue Numbers are in millions	7,207.336	10,639.203	17,220.742	22,227.122	28,439.371	27,424.648	18,997.993	13,171.388	8,680.343	7,080.523	5,416.68	4,245.329	2,933.685	2,029.63	1,464.093	1,045.467
Gross Profit Numbers are in millions	827.032	1,672.075	3,838.977	4,976.762	6,819.138	6,493.886	4,295.628	2,447.278	1,069.615	705.384	509.162	376.909	261.763	183.753	137.638	101.643
Gross Profit Ratio Numbers are in millions	0.103	0.136	0.182	0.183	0.193	0.191	0.184	0.157	0.11	0.091	0.086	0.082	0.082	0.083	0.086	0.089
Reseach & Development Expenses Numbers are in millions	14.616	22.678	11.563	8.914	6.971	0	0	0	0	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	170.64	304.69	428.135	534.316	663.145	705.004	469.752	209.408	107.132	41.285	26.597	24.545	22.332	17.074	15.194	11.596
Selling & Marketing Expenses Numbers are in millions	431.997	847.149	1,742.779	2,174.907	2,649.176	2,164.518	1,505.229	931.974	408.616	234.026	136.892	95.923	63.426	39.736	28.996	22.376
SG&A Numbers are in millions	602.636	1,151.839	2,170.913	2,709.223	3,312.321	2,869.521	1,974.981	1,141.382	515.748	275.311	163.489	120.467	85.758	56.81	44.19	33.972
Other Expenses Numbers are in millions	-286.202	430.448	621.505	662.241	904.925	780.739	415.303	16.871	9.547	6.02	-1.261	32.985	-1.028	16.797	12.033	12.029
Operating Expenses Numbers are in millions	891.808	1,604.964	2,803.981	3,380.378	4,224.217	3,650.26	2,390.285	1,414.289	648.994	378.904	236.227	167.205	116.018	76.725	58.809	46.852
Operating Income Numbers are in millions	-126.635	67.111	1,300.24	1,704.072	2,537.597	2,701.461	1,810.272	861.345	308.941	235.769	195.306	151.942	113.555	85.141	62.889	39.642
Operating Income Ratio Numbers are in millions	-0.016	0.005	0.062	0.063	0.072	0.08	0.078	0.055	0.032	0.03	0.033	0.033	0.036	0.038	0.039	0.035
Total Other Income Expenses Net Numbers are in millions	-8.782	-1,811.022	-835.222	-788.593	-2,435.222	-738.827	0.102	-154.92	-102.165	-84.721	-79.433	-61.863	-33.309	-23.852	-18.739	-16.32
Income Before Tax Numbers are in millions	-135.418	-1,743.912	465.018	915.479	102.376	1,962.634	1,810.375	878.069	318.456	241.759	193.502	147.841	112.437	83.176	60.09	38.471
Income Before Tax Ratio Numbers are in millions	-0.017	-0.142	0.022	0.034	0.003	0.058	0.078	0.056	0.033	0.031	0.033	0.032	0.035	0.038	0.038	0.034
Income Tax Expense Numbers are in millions	-167.389	-4.439	83.005	290.927	537.356	684.828	441.919	202.995	75.323	59.998	49.26	37.172	28.414	21.044	15.28	9.293
Net Income Numbers are in millions	20.318	-1,739.473	382.013	624.552	-434.98	1,277.806	1,368.456	590.759	235.939	180.987	143.555	110.651	84.057	62.109	44.757	29.178
Net Income Ratio Numbers are in millions	0.003	-0.141	0.018	0.023	-0.012	0.038	0.059	0.038	0.024	0.023	0.024	0.024	0.026	0.028	0.028	0.025
EPS Numbers are in millions	0.014	-1.18	0.26	0.42	-0.29	0.86	0.91	0.44	0.19	0.18	0.16	0.13	0.11	0.097	0.077	0.06
EPS Diluted Numbers are in millions	0.014	-1.18	0.26	0.42	-0.29	0.86	0.91	0.44	0.19	0.18	0.16	0.13	0.11	0.097	0.077	0.06
EBITDA Numbers are in millions	448.587	-542.864	1,619.457	1,993.413	2,812.419	2,935.803	2,019.115	1,151.826	488.205	359.048	285.467	215.269	150.097	105.256	75.599	50.549
EBITDA Ratio Numbers are in millions	0.056	-0.044	0.077	0.073	0.08	0.087	0.087	0.074	0.05	0.046	0.048	0.047	0.047	0.048	0.047	0.044

Realcan Pharmaceutical Group Co., Ltd.

SZSE:002589.SZ Add to watchlist

SZSE:002589.SZ